That entrepreneur is Paul Conyngham, who says he is launching Gamgee to offer “personalised mRNA cancer vaccines for dogs.” But his ambitions go well beyond dogs — and pets — with Gamgee’s website promising the company will harness AI and genetics to develop personalized treatments for a range of diseases and species, including humans. At